Gene · 2170
Papers3,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calpain-mediated cleavage generates a ZBTB18 N-terminal product that regulates HIF1A signaling and glioblastoma metabolism. | iScience | 2022 | 35800763 | PubTator, text mining | PubMed |
| Identification of Key Genes as Early Warning Signals of Acute Myocardial Infarction Based on Weighted Gene Correlation Network Analysis and Dynamic Network Biomarker Algorithm. | Front Immunol | 2022 | 35795669 | PubTator, text mining | PubMed |
| Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease. | Front Cardiovasc Med | 2022 | 35795372 | PubTator, text mining | PubMed |
| An integrated atlas of human placental development delineates essential regulators of trophoblast stem cells. | Development | 2022 | 35792865 | PubTator, text mining | PubMed |
| The Role of Lipid Metabolism in Gastric Cancer. | Front Oncol | 2022 | 35785165 | PubTator, text mining | PubMed |
| Editorial: Classical and Novel Biomarkers for Cardiovascular Disease. | Front Cardiovasc Med | 2022 | 35783859 | PubTator, text mining | PubMed |
| Biomarkers of Volume Overload and Edema in Heart Failure With Reduced Ejection Fraction. | Front Cardiovasc Med | 2022 | 35783848 | PubTator, text mining | PubMed |
| Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma. | Dis Markers | 2022 | 35783014 | PubTator, text mining | PubMed |
| Transcriptome analysis of human cholangiocytes exposed to carcinogenic 1,2-dichloropropane in the presence of macrophages in vitro. | Sci Rep | 2022 | 35780190 | PubTator, text mining | PubMed |
| Practical Blood Flow Restriction Training: New Methodological Directions for Practice and Research. | Sports Med Open | 2022 | 35763185 | PubTator, text mining | PubMed |
| Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. | Front Immunol | 2022 | 35757736 | PubTator, text mining | PubMed |
| Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review. | Pharmaceuticals (Basel) | 2022 | 35745668 | PubTator, text mining | PubMed |
| SAMM50 Regulates Thermogenesis of Beige Adipocytes Differentiated from Human Adipose-Derived Stem Cells by Balancing Mitochondrial Dynamics. | Int J Mol Sci | 2022 | 35743205 | PubTator, text mining | PubMed |
| Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. | Biomedicines | 2022 | 35740306 | PubTator, text mining | PubMed |
| Novel Insight Into the Role of ACSL1 Gene in Milk Production Traits in Buffalo. | Front Genet | 2022 | 35734439 | PubTator, text mining | PubMed |
| Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. | Nat Genet | 2022 | 35726067 | PubTator, text mining | PubMed |
| Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. | Oncoimmunology | 2022 | 35712121 | PubTator, text mining | PubMed |
| Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease. | Diabetes Metab Res Rev | 2022 | 35708187 | PubTator, text mining | PubMed |
| Regulation of Adipose Tissue Biology by Long-Chain Fatty Acids: Metabolic Effects and Molecular Mechanisms. | J Obes Metab Syndr | 2022 | 35691686 | PubTator, text mining | PubMed |
| Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies. | Int J Mol Sci | 2022 | 35682892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2170/papers?page=39